Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Nalidixic acid CRS, 100mg

Nalidixic acid CRS, 100mg

389-08-2

DISCOVER
NALOXONE HYDROCHLORIDE DIHYDRATE CRS (50 MG)

NALOXONE HYDROCHLORIDE DIHYDRATE CRS (50 MG)

51481-60-8

DISCOVER
NAPHAZOLINE HYDROCHLORIDE CRS(60 MG)

NAPHAZOLINE HYDROCHLORIDE CRS(60 MG)

550-99-2

DISCOVER
NAPHAZOLINE NITRATE CRS (10 MG)

NAPHAZOLINE NITRATE CRS (10 MG)

5144-52-5

DISCOVER
Naproxene

Naproxene

22204-53-1

DISCOVER
NAPHAZOLINE IMPURITY A CRS (15 MG)

NAPHAZOLINE IMPURITY A CRS (15 MG)

36321-43-4

DISCOVER
NAPROXEN CRS (50 MG)

NAPROXEN CRS (50 MG)

22204-53-1

DISCOVER
NEAMINE CRS (0.89 MG)

NEAMINE CRS (0.89 MG)

3947-65-7

DISCOVER
NEOHESPERIDIN- DIHYDROCHALCONE CRS (125 MG)

NEOHESPERIDIN- DIHYDROCHALCONE CRS (125 MG)

20702-77-6

DISCOVER
NEOHESPERIDIN- DIHYDROCHALCONE IMPURITY B CRS (10 MG)

NEOHESPERIDIN- DIHYDROCHALCONE IMPURITY B CRS (10 MG)

NA

DISCOVER
NEOMYCIN SULFATE CRS (50 MG)

NEOMYCIN SULFATE CRS (50 MG)

1405-10-3

DISCOVER
NEOMYCIN SULFATE FOR MICROBIOLOGICAL ASSAY CRS (25 MG)

NEOMYCIN SULFATE FOR MICROBIOLOGICAL ASSAY CRS (25 MG)

1405-10-3

DISCOVER